|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/451 | (2006.01) |
| A61P 25/28 | (2018.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/451 | (2013.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61K 45/06 | (2013.01) |
| (11) | Number of the document | 3570940 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18741607.8 |
| Date of filing the European patent application | 2018-01-18 | |
| (97) | Date of publication of the European application | 2019-11-27 |
| (45) | Date of publication and mention of the grant of the patent | 2023-12-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/014169 |
| Date | 2018-01-18 |
| (87) | Number | WO 2018/136600 |
| Date | 2018-07-26 |
| (30) | Number | Date | Country code |
| 201762448595 P | 2017-01-20 | US |
| (72) |
HAYDEN, Michael , IL
POULADI, Mahmoud, Abdulhossein , SG
|
| (73) |
Prilenia Neurotherapeutics Ltd. ,
10 HaMenofim Street, 4672561 Herzliya,
IL
National University of Singapore , 21 Lower Kent Ridge Road, Singapore 119077, SG Agency for Science, Technology and Research , 1 Fusionopolis Way 20-10 Connexis North, Singapore 138632, SG |
| (54) | PRIDOPIDINE FOR USE IN THE TREATMENT OF FRAGILE X SYNDROME |
| PRIDOPIDINE FOR USE IN THE TREATMENT OF FRAGILE X SYNDROME |